Drug-resistance of Mycobacterium tuberculosis in Patras, Greece

Monaldi Archives for Chest Disease - Pulmonary Series

Volumn 61, Issue 1, 2004, Pages 65-70

  Trakada, G ^a   Tsiamita, M ^a   Spiropoulos, Kostas ^a  

^a UNIVERSITY OF PATRAS   (Greece)

Author keywords

Drug resistance; Epdemiology; Tubercolosis

Indexed keywords

ETHAMBUTOL; ISONIAZID; STREPTOMYCIN;

ADOLESCENT; ADULT; AGE; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATE; CHEMOTHERAPY; CONTROLLED STUDY; FEMALE; GREECE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMIGRANT; MAJOR CLINICAL STUDY; MALE; MONITORING; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; SEX RATIO; TUBERCULOSIS;

EID: 4444300690     PISSN: 11220643     EISSN: 2465101X     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Epidemiologic basis of tuberculosis control. In: Rieder HL, ed. France, International Union Against Tuberculosis and Lung Disease, 1999; pp. 1-162.
2. Swedish Institute for Infectious Disease Control, Swedish Heart Lung Foundation. The Swedish Tuberculosis Index 1998. Tryck, Graphium Print and Distribution, Solna, 2000; pp. 1-38.
3. Lillebaek T, Andersen AB, Bauer J, et al. Risk of Mycobacterium tuberculosis transmission in a low incidence country due to immigration from high-incidence areas. J Clin Microbiol 2001; 39: 855-861.
4. Euro TB (In VS/KNCV) and the national coordinators for tuberculosis surveillance in the WHO European Region. Surveillance of tuberculosis in Europe. Report on tuberculosis case notified in 1998. Euro TB 2001; 1-105.
5. World Health Organization. Anti-tuberculosis drug resistance in the world. Report No. 2. World Health Organization Document WHO/CDS/TB2000. 278: 1-117. World Health Organization, Geneva, 2000.
6. Espinal MA, Laszlo A, Simonsen L, et al. Global trends in resistance to antituberculosis drugs. N Engl J Med 2001; 344: 1294-1303.
7. Mitchinson DA. Drug resistance in mycobacteria. Br Med Bull 1984; 40 (1): 84-90.
8. Goble M, Iseman MD, Madsen LA, et al. Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampicin. N Engl J Med 1993; 328: 527-532.
9. Fischl M, Uttamchandani R, Reyes R, et al. Nosocomial transmission of multidrug-resistant tuberculosis among HIV-infected persons. Florida and New York, 1988-1991. MMWR 1991; 40: 585-591.
10. Edlin BR, Tokars JI, Grieco MH, et al. An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome. N Engl J Med 1992; 326: 1514-1521.
11. Fischl MA, Uttamchandani R, Daikos GL, et al. An outbreak of tuberculosis caused by multible-drug-resistant tubercle bacilli among patients with HIV infection. Ann Intern Med 1992; 117: 177-183.
12. Mitchison DA. Development of streptomycin resistant strains of tubercle bacilli in pulmonary tuberculosis: result of simultaneous sensitivity tests in liquid and on solid media. Thorax 1950; 5: 144-161.
13. Canetti G. Present aspects of bacterial resistance in tuberculosis. Am Rev Respir Dis 1965; 92: 687-703.
14. Lambregts-van Weezenbeek CSB, Veen J. Control of drug-resistant tuberculosis. Tuber Lung Dis 1995; 76: 455-459.
15. Pablos-Mendez A, Lazlo A, Bustreo F. Anti-tuberculosis drug resistance in the world. Publication No. WHO/GTP/97.229. Geneva. World Health Organization Global Tuberculosis Programme, 1997.
16. Crofton J, Chaulet P, Maher D. Guidelines for the management of drug-resistant tuberculosis. Publication No WHO/TB96.210 (Rev. 1). Geneva. World Health Organization, 1997.
17. Loddenkemper R, Sagebiel D, Brendel A. Strategies against multidrug-resistant tuberculosis. Eur Respir J 2002; 20: Suppl. 36, 66s-77s.
18. Raviglione MC, Sudre P, Rieder HL, et al. Secular trends of tuberculosis in Western Europe. Bull World Health Organ 1993; 71: 297-306.
19. Rieder HL, Zellweger J-P, Raviglione MC, et al. Tuberculosis controlin Europe and international migration. Eur Respir J 1994; 7: 1545-1553.
20. World Health Organization/International Union against Tuberculosis and Lung Disease. Antituberculosis drug resistance in the world. Report No. 2. Prevalence and trends (2000). Publication No. WHO/CDS/TB/2000.278. Geneva, Communicable Diseases, World Health Organization, 1994.
21. Raviglione M. The TB epidemic from 1992 to 2002. Tuberculosis 2003; 83: 4-14.
22. Migliori GB, Centis R. Problems to control TB in eastern Europe and consequences in low incidences countries. Monaldi Arch Chest Dis 2002; 57 (5-6): 285-290.
23. Centers for Disease Control. Tuberculosis - United States, First 39 weeks, 1985. MMWR 1985; 34: 625-627.
24. Reichman LB. The U-shaped curve of concern. Am Rev Respir Dis 1991; 144: 741-742.
25. Espinal MA, Laszlo A, Simonsen L, et al. Global trends in resistance to antituberculosis drugs. N Engl J Med 2001; 344: 1294-1303.
26. Becerra MC, Farmer PE & Kim JY. The problem of drug-resistant tuberculosis. In: The Global Impact of Drug-resistant Tuberculosis. Pp 1-38. Program in Infectious Disease and Social Change. Department of Social Medicine, Harvard Medical School, Boston, 1999.
27. Bouvet E, Casalino E, Mendoza-Sassi G, et al. A nosocomial outbreak of multi-drug resistant Mycobacterium bovis among HIV-infected patients: a case-control study. AIDS 1993; 7: 1453-1460.
28. Cotte L, Fougerat F, Trepo C. Nosocomial transmission of multi-drug resistant tuberculosis between AIDS patients. Tuber Lung Dis 1992; 73: 397-398.
29. Pena JM, Ortega A. Emergence of drug-resistant tuberculosis in Madrid: the challenge of tuberculosis. Proceedings of the Lancet Conference, September 14 and 15 1995. London, The Lancet Ltd 1995; p. 31.
30. Sudre P, ten Dam G, Kochi A. Tuberculosis: a global overview of the situation today. Bull World Health Organ 1992; 70: 149-159.
31. WHO. Expanded Programme on Immunization. Immunization schedules in the WHO European Region 1995. Wkly Epidemiol Rec 1995; 70: 221-228.
32. World Health Organization. Guidelines for the Management of Drug - resistant Tuberculosis. WHO/TB/96.210 (rev. 2), Geneva, 1997.
33. World Health Organization. Tuberculosis handbook. World Health Organization Document WHO/TB/98.253: 1-122. World Health Organization. Geneva, 1998.